Jump to navigation
Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate. The results of this trial in Asia (involving Sanofi Pasteur’s dengue vaccine candidate) were published this summer, July 11, in The Lancet.
This post was originally published on the Dengue Vaccine Initiative blog.
Human hookworm, schistosomiasis, Chagas disease and leishmaniasis are some of the most devastating diseases in poverty with no licensed vaccine available.
By: Alexa Bednarz
This post was originally published on the Gates Foundation's Impatient Optimists blog.
By Dr. Ciro de Quadros